Abstract
AstraZeneca Canada Inc. v Apotex Inc., 2017 SCC 36, Supreme Court of Canada, 30 June 2017 The Supreme Court of Canada unanimously rejected the ‘promise doctrine’ in determining a patent’s usefulness under section 2 of Canada’s Patent Act.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Paper Title
Journal
Date
